Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Rang in Aktien #31190
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Aktienkurs
$0.03808538
Marktkapitalisierung
$14.04M
Veränderung (1 Tag)
-3.57%
Veränderung (1 Jahr)
6.63%
Land
AU
Handel BCAL Diagnostics Limited (BDX)

Kategorie

Kursverlauf für BCAL Diagnostics Limited (BDX)
Höchster Schlusskurs: $0.04 am 2026-08-01

Niedrigster Schlusskurs: $0.15 am 2021-07-01
Kursverlauf der Aktie von BCAL Diagnostics Limited von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -14.06%
2025 6.49%
2024 -5.30%
2023 59.08%
2022 -54.80%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$587.61 20.53%
US
$200.84 -3.91%
US
$24.23 79.49%
CN
$314.11 94.92%
US
$556.85 -12.70%
US